Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-067431

Chief Financial Officer sold 42,120 shares at an average $80.48 ($3,389,756)

  • Chief Financial Officer acquired 42,120 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2025-07-09 Option exercise 10b5-1 +42,120 $6.88 $289,786 159,035 D: show line 1 in the form
Smith Hunter C Chief Financial Officer 2025-07-09 Sale 10b5-1 −17,113 $75.38 $1,290,050 141,922 D: show line 2 in the form
Smith Hunter C Chief Financial Officer 2025-07-09 Sale 10b5-1 −1,607 $76.17 $122,406 140,315 D: show line 3 in the form
Smith Hunter C Chief Financial Officer 2025-07-09 Sale 10b5-1 −23,400 $84.50 $1,977,300 116,915 D: show line 4 in the form
Open-market sales · 42,120 sh · avg $80.48 · $3,389,756

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Smith Hunter C Chief Financial Officer 2025-07-09 Option exercise · Stock Options (Right to Buy) 10b5-1 −42,120 28,088 D: show line 5 in the form
Loading xslF345X05/tm2520691-4_4seq1.xml…